Heparin in sepsis treatment – Authors' reply

738 www.thelancet.com Vol 370 September 1, 2007 1 Alexander JL, Kotz K, Dennerstein L, Kutner SJ, Wallen K, Notelovitz M. The eff ects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials. Menopause 2004; 11: 749–65. 2 Johannsson G, Burman P, Wiren L, et al. Low dose dehydroepiandrosterone aff ects behavior in hypopituitary androgen-defi cient women: a placebo-controlled trial. J Clin Endocrinol Metab 2002; 87: 2046–52. 3 van Thiel SW, Romijn JA, Pereira AM, et al. Eff ects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insuffi ciency: a randomized, placebo-controlled, cross-over trial. J Clin Endocrinol Metab 2005; 90: 3295–303. 4 Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insuffi ciency. N Engl J Med 1999; 341: 1013–20. 5 Lovas K, Gebre-Medhin G, Trovik TS, et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefi t for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 2003; 88: 1112–18. Whipple’s disease and sarcoidosis